1、S-1 1 ea0295800-s1_biomx.htm REGISTRATION STATEMENTAs filed with the Securities and Exchange Commission on June 29,2026Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM S-1 REGISTRATION STATEMENTUNDER THE SECURITIES ACT OF 1933 BIOMX INC.(Exact Name of Regi
2、strant as Specified in its Charter)Delaware 2836 82-3364020(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)BiomX Inc.850 New Burton Road,Suite 201Dover,Delaware 19904Telephone:+972 52 437 4900(Ad
3、dress,including zip code,and telephone number,including area code,of registrants principal executive offices)Michael OsterChief Executive OfficerBiomX Inc.850 New Burton Road,Suite 201Dover,Delaware 19904Telephone:+972 52 437 4900(Name,address,including zip code,and telephone number,including area c
4、ode,of agent for service)Copies to:David Aboudi,Esq.Aboudi Legal Group PLLC745 Fifth Avenue,Suite 500New York,New York 10151Telephone:(646)898-2006 Approximate date of commencement of proposed sale to the public:From time to time after the effective date of this RegistrationStatement.If any of the s
5、ecurities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933,other than securities offered only in connection with dividend or interest reinvestment plans,check thefollowing box.If this Form is filed to register addit
6、ional securities for an offering pursuant to Rule 462(b)under the Securities Act,please checkthe following box and list the Securities Act registration statement number of the earlier effective registration statement for thesame offering.If this Form is a post-effective amendment filed pursuant to R